(NP (NP (NP (NN Apoptosis) (NN signaling) (NNS pathways)) (PP (IN in) (NP (JJ normal) (NN T) (NNS cells))) (: :)) (NP (NP (JJ differential) (NN activity)) (PP (IN of) (NP-COOD (NP (NN Bcl-2)) (CC and) (NP (JJ IL-1beta-converting) (NN enzyme) (NN family) (NN protease) (NNS inhibitors)))) (PP (IN on) (NP (ADJP-COOD (ADJP (NP (NN glucocorticoid-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ Fas-mediated))) (NN cytotoxicity))) (. .)))
(S (NP-SBJ-78 (JJ Fas-mediated) (NN apoptosis)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (S (NP-SBJ (-NONE- *-78)) (VP (VBG regulating) (NP (NP (DT the) (JJ immune) (NN response)) (PP (IN in) (NP (JJ peripheral) (NN T) (NNS cells)))))))) (. .))
(S (NP-SBJ (NP (NN Restimulation)) (PP (IN of) (NP (NN T) (NN cell) (NNS blasts)))) (VP (VBZ up-regulates) (NP-COOD (NP (NN Fas)) (CC and) (NP (NN Fas) (NN ligand) (NN expression))) (, ,) (PP (IN with) (S (NP-SBJ (JJ subsequent) (NN interaction)) (VP (VBG leading) (PP (TO to) (NP (NN cell) (NN death))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NN Overexpression)) (PP (IN of) (NP (NN Bcl-2))) (PP (IN in) (NP (NN tumor) (NNS cells)))) (VP (VBZ blocks) (NP (NP (NN apoptosis)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (JJ many) (NNS stimuli))))))) (, ,) (CC but) (S (NP-SBJ-79 (NP (NN inhibition)) (PP (IN of) (NP (JJ Fas-mediated) (NN killing)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP-TMP (RB consistently)) (VBN observed) (NP (-NONE- *-79)))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NN behavior)) (PP (IN of) (NP (NN Bcl-2))) (PP (IN in) (NP (JJ normal) (NNS cells))))))) (, ,) (NP-SBJ-80 (NN T) (NN cell) (NNS blasts)) (VP (VBD were) (VP (ADVP-TMP (RB transiently)) (VBN transfected) (NP (-NONE- *-80)) (PP (IN with) (NP-COOD (NP (NN Bcl-2)) (CC and) (NP (JJ related) (NN gene) (NNS products)))) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN effect)) (PP (IN on) (NP (JJ apoptotic) (NN signaling))))))))) (. .))
(S-COOD (S (NP-SBJ (NP (JJ Transient) (NN overexpression)) (PP (IN of) (NP (NN Bcl-2))) (PP (IN in) (NP (UCP-COOD (NP (NN mouse)) (CC and) (ADJP (JJ human))) (NN T) (NN cell) (NNS blasts)))) (VP (VBD did) (RB not) (VP (VB block) (NP (JJ Fas-mediated) (NN apoptosis))))) (, ,) (IN whereas) (S (NP-SBJ-81 (ADJP-COOD (ADJP (NP (NN etoposide-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ glucocorticoid-induced))) (NN cytotoxicity)) (VP (VBD was) (VP (ADVP (RB potently)) (VBN inhibited) (NP (-NONE- *-81))))) (. .))
(S (NP-SBJ (NP (NN Expression)) (PP (IN of) (NP-COOD (NP (NN Bcl-xL)) (CC and) (NP (NN adenovirus) (NN E1B) (NN 19K))))) (VP (VBD did) (RB not) (VP (VB interfere) (PP (IN with) (NP (JJ anti-Fas) (NN killing))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (JJ interleukin-1beta-converting) (NN enzyme) (NN family) (NN protease) (NNS inhibitors) (NP-COOD (NP (NN Ac-DEVD-CHO)) (CC and) (NP (NN CrmA)))) (VP (VBD blocked) (NP (JJ Fas-mediated) (NN apoptosis))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (JJ peripheral) (NN T) (NNS cells)) (VP (VBP use) (NP (NP (JJ distinct) (NN apoptosis) (NN signaling) (NNS pathways)) (PP (IN with) (NP (NP (JJ differential) (NN sensitivity)) (PP (TO to) (NP-COOD (NP (NN Bcl-2)) (CC and) (NP (JJ interleukin-1beta-converting) (NN enzyme) (NN family) (NN protease) (NNS inhibitors))))))))))) (. .))
(S (SBAR (IN Since) (S (NP-SBJ (NN T) (NNS cells)) (ADVP (RB normally)) (VP (VBP express) (NP-COOD (NP (NN Bcl-2)) (CC and) (NP (NN Bcl-xL))) (PP-TMP (VBG following) (NP (NN activation)))))) (, ,) (NP-SBJ (PRP$ their) (NN inability) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB block) (NP (JJ Fas-mediated) (NN apoptosis)))))) (VP (MD may) (VP (VB allow) (PP (IN for) (NP-COOD (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (JJ self-reactive) (NNS cells)))) (CC and) (NP (NP (DT the) (JJ appropriate) (NN regulation)) (PP (IN of) (NP (JJ immune) (NNS responses)))))))) (. .))
